The US National Institutes of Health failed to ensure the timely reporting of results in roughly half of the clinical trials it funded in 2019 and 2020, including many overseen by NIH scientists, according to the findings of a new report released by the Department of Health and Human Services’ Office of Inspector General. In some cases, the agency allowed researchers who failed to meet these federal reporting requirements to launch new trials as well, drawing intense criticism from research transparency advocates and at least one former director of ClinicalTrials.gov, the federal database in which scientists are legally required to post updates on clinical research.
“NIH has severely let down patients and taxpayers since 2007, when trial reporting first became mandatory,” Till Bruckner, the founder of Transparimed, a group that tracks issues pertaining to clinical trial transparency, tells STAT News. “As this report documents, NIH for over a decade turned ...






















